Clinical Trial Update: MSCS in BURSTDR Patients [NA]

View source ↗

Summary

A clinical trial update indicates MSCS is being studied in BURSTDR patients with failed back surgery syndrome and persistent spinal pain syndrome type II, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Failed Back Surgery Syndrome
• Neuropathic Pain
• Persistent Spinal Pain Syndrome Type Ii

Drugs mentioned

• MSCS (mesenchymal stem cell suspension)

Snippet

Sponsor: Jessa Hospital | Conditions: FBSS, PSPSII | NA | Status: ENROLLING_BY_INVITATION